Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,477
Closed -$105K 1816
2023
Q3
$105K Buy
11,477
+185
+2% +$1.66K ﹤0.01% 1597
2023
Q2
$82.1K Buy
11,292
+490
+5% +$4.23K ﹤0.01% 1590
2023
Q1
$91.4K Sell
10,802
-16,966
-61% -$153K ﹤0.01% 1571
2022
Q4
$209K Buy
+27,768
New +$215K ﹤0.01% 1420
2022
Q2
Sell
-24,795
Closed -$278K 1398
2022
Q1
$278K Buy
+24,795
New +$211K 0.01% 1143

Other funds holding EOLS

Cetera Advisors's EOLS Position: Q4 2023 in Review

Cetera Advisors sold out of Evolus (EOLS) in Q4 2023, closing a stake of 11,477 shares — an estimated $105K sold.

Cetera Advisors first reported a position in EOLS in Q1 2022 and held it in 5 quarters. The position peaked at $278K in Q1 2022. 151 funds tracked by Wall St. Rank hold EOLS as of Q4 2023.

  • Cetera Advisors reported no remaining Evolus position as of Q4 2023 after selling out during the quarter.
  • Cetera Advisors sold 11,477 Evolus shares in Q4 2023, an estimated $105K.
  • Cetera Advisors first reported a position in Evolus in Q1 2022 and held it in 5 quarters.
  • Cetera Advisors's Evolus position peaked at $278K in Q1 2022.
  • 151 funds tracked by Wall St. Rank held Evolus as of Q4 2023.

Based on Cetera Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.